{"title": [{"text": "Effective Adaptation of a Hidden Markov Model-based Named Entity Recognizer for Biomedical Domain", "labels": [], "entities": []}], "abstractContent": [{"text": "In this paper, we explore how to adapt a general Hidden Markov Model-based named entity recognizer effectively to biomedical domain.", "labels": [], "entities": [{"text": "Hidden Markov Model-based named entity recognizer", "start_pos": 49, "end_pos": 98, "type": "TASK", "confidence": 0.6474855045477549}]}, {"text": "We integrate various features, including simple deterministic features, morphological features, POS features and semantic trigger features, to capture various evidences especially for biomedical named entity and evaluate their contributions.", "labels": [], "entities": []}, {"text": "We also present a simple algorithm to solve the abbreviation problem and a rule-based method to deal with the cascaded phenomena in biomedi-cal domain.", "labels": [], "entities": []}, {"text": "Our experiments on GENIA V3.0 and GENIA V1.1 achieve the 66.1 and 62.5 F-measure respectively, which outperform the previous best published results by 8.1 F-measure when using the same training and testing data.", "labels": [], "entities": [{"text": "GENIA V3.0", "start_pos": 19, "end_pos": 29, "type": "DATASET", "confidence": 0.8822480142116547}, {"text": "GENIA V1.1", "start_pos": 34, "end_pos": 44, "type": "DATASET", "confidence": 0.8816535770893097}, {"text": "F-measure", "start_pos": 71, "end_pos": 80, "type": "METRIC", "confidence": 0.9952892065048218}, {"text": "F-measure", "start_pos": 155, "end_pos": 164, "type": "METRIC", "confidence": 0.9878410696983337}]}], "introductionContent": [{"text": "As the research in biomedical domain has grown rapidly in recent years, a huge amount of nature language resources have been developed and become a rich knowledge base.", "labels": [], "entities": []}, {"text": "The technique of named entity (NE) recognition (NER) is strongly demanded to be applied in biomedical domain.", "labels": [], "entities": [{"text": "named entity (NE) recognition (NER)", "start_pos": 17, "end_pos": 52, "type": "TASK", "confidence": 0.7396570079856448}]}, {"text": "Since in previous work, many NER systems have been applied successfully in newswire domain (), more and more explorations have been done to port existing NER system into biomedical domain ().", "labels": [], "entities": []}, {"text": "However, compared with those in newswire domain, these systems haven't got high performance.", "labels": [], "entities": []}, {"text": "It is probably because of the following factors of biomedical NE (): 1.", "labels": [], "entities": [{"text": "biomedical NE", "start_pos": 51, "end_pos": 64, "type": "TASK", "confidence": 0.697654515504837}]}, {"text": "Some modifiers are often before basic NEs, e.g. activated B cell lines, and sometimes biomedical NEs are very long, e.g. 47 kDa sterol regulatory element binding factor.", "labels": [], "entities": []}, {"text": "This kind of factor highlights the difficulty for identifying the boundary of NE.", "labels": [], "entities": []}, {"text": "2. Two or more NEs share one head noun by using conjunction or disjunction construction, e.g. 91 and 84 kDa proteins.", "labels": [], "entities": []}, {"text": "It is hard to identify these NEs respectively.", "labels": [], "entities": []}, {"text": "3. An entity maybe found with various spelling forms, e.g. N-acetylcysteine, N-acetyl-cysteine, NAcetylCysteine, etc.", "labels": [], "entities": []}, {"text": "Since the use of capitalization is casual, the capitalization information may not be so evidential in this domain.", "labels": [], "entities": []}, {"text": "One NE maybe embedded in another NE, e.g. <PROTEIN><DNA> kappa 3</DNA> binding factor </PROTEIN>.", "labels": [], "entities": []}, {"text": "More effort must be made to identify this kind of NE.", "labels": [], "entities": [{"text": "NE", "start_pos": 50, "end_pos": 52, "type": "TASK", "confidence": 0.7587740421295166}]}, {"text": "5. Abbreviations are frequently used in biomedical domain, e.g. TCEd, IFN, TPA, etc.", "labels": [], "entities": [{"text": "Abbreviations", "start_pos": 3, "end_pos": 16, "type": "METRIC", "confidence": 0.983242392539978}]}, {"text": "Since abbreviations don't have many evidences for certain NE class, it is difficult to classify them correctly.", "labels": [], "entities": []}, {"text": "These factors above make NER in biomedical domain difficult.", "labels": [], "entities": [{"text": "NER", "start_pos": 25, "end_pos": 28, "type": "TASK", "confidence": 0.9942190647125244}]}, {"text": "Therefore, it is necessary to explore more evidential features and more effective methods to cope with such difficulties.", "labels": [], "entities": []}, {"text": "In this paper, we will study how to adapt a general Hidden Markov Model (HMM)-based NE recognizer ( to biomedical domain.", "labels": [], "entities": [{"text": "NE recognizer", "start_pos": 84, "end_pos": 97, "type": "TASK", "confidence": 0.8230371475219727}]}, {"text": "We specially explore various evidences for biomedical NE and propose methods to cope with abbreviations and cascaded phenomena.", "labels": [], "entities": [{"text": "biomedical NE", "start_pos": 43, "end_pos": 56, "type": "TASK", "confidence": 0.8551075756549835}]}, {"text": "As a result, features (simple deterministic features, morphological features, part-of-speech features and head noun trigger features) and methods (abbreviation recognition algorithm and rule-based cascaded phenomena resolution) are integrated in our system.", "labels": [], "entities": [{"text": "abbreviation recognition", "start_pos": 147, "end_pos": 171, "type": "TASK", "confidence": 0.7931347787380219}, {"text": "rule-based cascaded phenomena resolution", "start_pos": 186, "end_pos": 226, "type": "TASK", "confidence": 0.6135428249835968}]}, {"text": "The experiment shows that system outperforms the best published system by 8.1 F-measure.", "labels": [], "entities": [{"text": "F-measure", "start_pos": 78, "end_pos": 87, "type": "METRIC", "confidence": 0.9765680432319641}]}, {"text": "In Section 2, we will introduce the HMMbased NE recognizer briefly.", "labels": [], "entities": [{"text": "HMMbased NE recognizer", "start_pos": 36, "end_pos": 58, "type": "TASK", "confidence": 0.5826913118362427}]}, {"text": "In Section 3, we will focus on the features that we have used.", "labels": [], "entities": []}, {"text": "The methods and the adaptations of different features will be discussed in detail.", "labels": [], "entities": []}, {"text": "In Section 5 and 6, we will present the solutions of abbreviation and cascaded phenomena.", "labels": [], "entities": []}, {"text": "Finally, our experiment results will be presented and the contributions of different features will be analyzed in Section 7.", "labels": [], "entities": []}], "datasetContent": [{"text": "The system is evaluated using standard \"precision/recall/F-measure\", in which \"F-measure\" is defined as F-measure = (2PR) / (P+R).", "labels": [], "entities": [{"text": "precision", "start_pos": 40, "end_pos": 49, "type": "METRIC", "confidence": 0.9986587762832642}, {"text": "recall", "start_pos": 50, "end_pos": 56, "type": "METRIC", "confidence": 0.7454054951667786}, {"text": "F-measure", "start_pos": 57, "end_pos": 66, "type": "METRIC", "confidence": 0.7303788065910339}, {"text": "F-measure", "start_pos": 79, "end_pos": 88, "type": "METRIC", "confidence": 0.9925997257232666}, {"text": "F-measure", "start_pos": 104, "end_pos": 113, "type": "METRIC", "confidence": 0.9866518974304199}]}, {"text": "We evaluate our NER system on both V3.0 and V1.1, each of which has been split into a training set and a testing set.", "labels": [], "entities": [{"text": "NER", "start_pos": 16, "end_pos": 19, "type": "TASK", "confidence": 0.9194304943084717}, {"text": "V3.0", "start_pos": 35, "end_pos": 39, "type": "DATASET", "confidence": 0.8883479237556458}, {"text": "V1.1", "start_pos": 44, "end_pos": 48, "type": "DATASET", "confidence": 0.8513399362564087}]}, {"text": "As for V1.1, we divide the corpus into 590 abstracts (136K words) as training set and the rest 80 abstracts (17K words) as testing set.", "labels": [], "entities": []}, {"text": "As for V3.0, we use the same testing set as V1.1 and the rest 1920 abstracts (447K words) as training set.", "labels": [], "entities": [{"text": "V3.0", "start_pos": 7, "end_pos": 11, "type": "DATASET", "confidence": 0.8603764176368713}, {"text": "V1.1", "start_pos": 44, "end_pos": 48, "type": "DATASET", "confidence": 0.9020330905914307}]}], "tableCaptions": [{"text": " Table 1: Simple deterministic features", "labels": [], "entities": []}, {"text": " Table 3: Comparison of POS tagger using dif- ferent training data", "labels": [], "entities": [{"text": "POS tagger", "start_pos": 24, "end_pos": 34, "type": "TASK", "confidence": 0.7046760022640228}]}, {"text": " Table 7, several findings are concluded:  1) With only F sd , our system achieves a basic  level F-measure of 29.4.  2) F m shows the positive effect with 2.4 F- measure improvement based on the basic level.", "labels": [], "entities": [{"text": "F-measure", "start_pos": 98, "end_pos": 107, "type": "METRIC", "confidence": 0.6784822344779968}, {"text": "F m", "start_pos": 121, "end_pos": 124, "type": "METRIC", "confidence": 0.9507721066474915}, {"text": "F- measure", "start_pos": 160, "end_pos": 170, "type": "METRIC", "confidence": 0.9721313714981079}]}, {"text": " Table 8: Effects of solution for abbr. and casc.", "labels": [], "entities": []}]}